Back to Agenda

Looking forward to this session? Share it!

  • Factors leading to the increased need and utilization of RWD
  • The 21st Cure Act of Congress and FDA’s mandate to develop RWE program for drug development
  • Types and roles of RWD in the drug development life cycle: past and present
  • How we are currently able to leverage RWE to inform clinical trials by phase
  • Example for leveraging RWE to inform and support clinical trials
  • Current limitations of RWD and RWE